These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 31315613)

  • 1. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between skeletal muscle mass to visceral fat area ratio and arterial stiffness in Chinese patients with type 2 diabetes mellitus.
    Xu J; Pan X; Liang H; Lin Y; Hong Y; Si Q; Shen F; Gu X
    BMC Cardiovasc Disord; 2018 May; 18(1):89. PubMed ID: 29739314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
    Xing M; Ni Y; Zhang Y; Zhao X; Yu X
    Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
    Li G; Rios RS; Wang XX; Yu Y; Zheng KI; Huang OY; Tang LJ; Ma HL; Jin Y; Targher G; Byrne CD; Pan XY; Zheng MH
    Br J Nutr; 2022 Jun; 127(11):1613-1620. PubMed ID: 34176541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
    Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
    J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation.
    Murai J; Nishizawa H; Otsuka A; Fukuda S; Tanaka Y; Nagao H; Sakai Y; Suzuki M; Yokota S; Tada H; Doi M; Fujishima Y; Kita S; Funahashi T; Maeda N; Nakamura T; Shimomura I
    Cardiovasc Diabetol; 2018 Aug; 17(1):112. PubMed ID: 30077183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
    Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
    J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    Mai Z; Chen Y; Mao H; Wang L
    J Diabetes; 2024 Jun; 16(6):e13569. PubMed ID: 38751375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
    Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
    J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.
    Hazim A; Purnamasari D; Kalista KF; Lesmana CRA; Nugroho P
    Diabetes Metab Syndr; 2019; 13(2):1431-1435. PubMed ID: 31336502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
    Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
    Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
    Han E; Lee YH; Ahn SH; Cha BS; Kim SU; Lee BW
    Gut Liver; 2024 May; 18(3):509-519. PubMed ID: 38013477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
    J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus.
    Low S; Ng TP; Goh KS; Moh A; Khoo J; Ang K; Yap P; Cheong CY; Tang WE; Lim Z; Subramaniam T; Sum CF; Lim SC
    J Diabetes Complications; 2024 Feb; 38(2):108672. PubMed ID: 38183854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
    Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
    J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes.
    Liu D; Zhong J; Wen W; Ruan Y; Zhang Z; Sun J; Chen H
    Diabetes Metab Syndr Obes; 2021; 14():3733-3742. PubMed ID: 34471365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
    Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
    Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.